BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 37142534)

  • 21. Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression.
    Paik JH; Koh J; Han B; Kim S; Lee KR; Lee S; Lee JO; Kim TM; Kim WY; Jeon YK
    Hum Pathol; 2023 Jan; 131():47-60. PubMed ID: 36495942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.
    Wai CMM; Chen S; Phyu T; Fan S; Leong SM; Zheng W; Low LCY; Choo SN; Lee CK; Chung TH; Ban KHK; Ghosh S; Lie S; Kato S; Nakamura S; Takahashi E; Ko YH; Khoury JD; Chuang SS; Au-Yeung RKH; Tan SY; Lim ST; Ong CK; Ho YH; Poon LM; De Mel S; Jeyasekharan AD; Chng WJ; Otto F; Quintanilla-Martinez L; Zanardi F; Iannelli F; Tripodo C; Pitt JJ; Ng SB
    Haematologica; 2022 Aug; 107(8):1864-1879. PubMed ID: 35021606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Pathogenesis of Peripheral T Cell Lymphoma.
    Sakata-Yanagimoto M; Chiba S
    Curr Hematol Malig Rep; 2015 Dec; 10(4):429-37. PubMed ID: 26431836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STX11 functions as a novel tumor suppressor gene in peripheral T-cell lymphomas.
    Yoshida N; Tsuzuki S; Karube K; Takahara T; Suguro M; Miyoshi H; Nishikori M; Shimoyama M; Tsukasaki K; Ohshima K; Seto M
    Cancer Sci; 2015 Oct; 106(10):1455-62. PubMed ID: 26176172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy of Peripheral T Cell Lymphoma: Focus on Nodal Subtypes.
    Allen PB; Pro B
    Curr Oncol Rep; 2020 Apr; 22(5):44. PubMed ID: 32297075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapy.
    Abramson JS; Feldman T; Kroll-Desrosiers AR; Muffly LS; Winer E; Flowers CR; Lansigan F; Nabhan C; Nastoupil LJ; Nath R; Goy A; Castillo JJ; Jagadeesh D; Woda B; Rosen ST; Smith SM; Evens AM
    Ann Oncol; 2014 Nov; 25(11):2211-2217. PubMed ID: 25193992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA3 expression correlates with poor prognosis and tumor-associated macrophage infiltration in peripheral T cell lymphoma.
    Zhang W; Wang Z; Luo Y; Zhong D; Luo Y; Zhou D
    Oncotarget; 2016 Oct; 7(40):65284-65294. PubMed ID: 27589565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SOHO State of the Art Updates and Next Questions | Challenging Cases in Rare T-Cell Lymphomas.
    Bhansali RS; Barta SK
    Clin Lymphoma Myeloma Leuk; 2023 Sep; 23(9):642-650. PubMed ID: 37302955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation.
    Zain J
    Cancer Treat Res; 2019; 176():269-287. PubMed ID: 30596223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.
    Rüdiger T; Weisenburger DD; Anderson JR; Armitage JO; Diebold J; MacLennan KA; Nathwani BN; Ullrich F; Müller-Hermelink HK;
    Ann Oncol; 2002 Jan; 13(1):140-9. PubMed ID: 11863096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
    Rogers AM; Brammer JE
    Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel targeted therapies in peripheral T cell lymphoma.
    Jagadeesh D; Smith MR
    Discov Med; 2013 Jun; 15(85):367-78. PubMed ID: 23819951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations.
    Nicolae A; Bouilly J; Lara D; Fataccioli V; Lemonnier F; Drieux F; Parrens M; Robe C; Poullot E; Bisig B; Bossard C; Letourneau A; Missiaglia E; Bonnet C; Szablewski V; Traverse-Glehen A; Delfau-Larue MH; de Leval L; Gaulard P
    Mod Pathol; 2022 Aug; 35(8):1126-1136. PubMed ID: 35301414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features.
    Wang T; Feldman AL; Wada DA; Lu Y; Polk A; Briski R; Ristow K; Habermann TM; Thomas D; Ziesmer SC; Wellik LE; Lanigan TM; Witzig TE; Pittelkow MR; Bailey NG; Hristov AC; Lim MS; Ansell SM; Wilcox RA
    Blood; 2014 May; 123(19):3007-15. PubMed ID: 24497534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
    Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
    Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
    Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
    Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive genomic analysis identifying heterogeneity in peripheral T-cell lymphoma.
    Yoshida N; Yamada K; Ohshima K
    Cancer Sci; 2021 Apr; 112(4):1339-1347. PubMed ID: 33576080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High intratumoural galectin-1 expression predicts adverse outcome in ALK
    Holst JM; Ludvigsen M; Hamilton-Dutoit SJ; Bendix K; Plesner TL; Nørgaard P; Møller MB; Steiniche T; Rabinovich GA; d'Amore F; Pedersen MB
    Hematol Oncol; 2020 Feb; 38(1):59-66. PubMed ID: 31834627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approach to nodal-based T-cell lymphomas.
    de Leval L
    Pathology; 2020 Jan; 52(1):78-99. PubMed ID: 31785821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.